ÂÜÀòÂÒÂ×

Ms. Nast has served on our board since August 2021. Ms. Nast has spent her career in executive level positions with both large multinational companies and early-stage companies in the medical industry. Most recently, Ms. Nast served as Chief Operating Officer at MindMed, a biotech company developing psychedelic-inspired therapies. She is a recognized expert in product development and commercialization and has extensive experience in the management of complex, multinational partner programs and has played a critical role in the development and commercialization of over 100 products. Previously, Ms. Nast was COO at NuGen, a genomics company, and served in executive level positions at Inhale Therapeutics (Nektar), Syva (a division of Syntex Pharmaceuticals,) BioRad and Pfizer.